Advanced search
Publication Cover
Journal of Chemotherapy Volume 9, 1997 - Issue 6
Submit an article Journal homepage
12
Views
3
CrossRef citations to date
0
Altmetric
Articles

Results of Treatment with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) for Non-Hodgkin’s Aggressive Lymphoma Analyzed According to the International Prognostic Index

F. Aydin
,
S. Ulusoy
&
E. OVALI
Pages 446-451 | Published online: 18 Jul 2013

References

  • Shipp MA, Mauch PM, Harris NL. Non-Hodgkin's Lymphomas in: De Vita VT Jr, Hellamn S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology, 5th edition, Philadelphia: Lippincott, 1997: 2165-2220.
  • Shipp M, Harrington D, Anderson J et al. International Non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993; 329: 987–994.
  • Dana BW, Dahlberg S, Nathwani BN, et al. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoim-munotherapy. J Clin Oncol 1993; 11: 644–651.
  • Kwak LW, Halper J, Olshen RA et al. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol 1990; 8: 963–977.
  • Dixon DD, Neilan B, Jones SE et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lym-phoma: the Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295–305.
  • Ciampi A, Bush RS, Gaspodarowicz M. An approach to dassifiying prognostic factors related to survival experience for non-Hodgkin's lymphoma patients: based on a series of 982 patients: 1967-1975. Cancer 1981; 47: 621–627.
  • Hoskins PJ, Ng V, Spinelli JJ, Klimo P, Connors JM. Prognostic variables in patients with diffuse large-cell lym-phoma treated with MACOP-B. J Clin Oncol 1991; 9: 220–226.
  • Stein RS, Greer JP, Flexner JM et al. Large cell lym-phomas: clinical and prognostic features. J Clin Oncol 1990; 8: 1370-1379.
  • Sylmen DJ, Miller TP, Lippman SM et al. Immunobiologic factors predictive of clinical outcome in dif-fuse large-cell lymphoma. J Clin Oncol 1990; 8: 986–993.
  • Grogan TM, Miller TP. Natural history and pretreatment evaluation of non-Hodgkin's lymphomas. In: Cancer Treatment. Haskell CM, ed. Philadelphia: W.B. Saunders Company 1995; 979-1005.
  • Fisher RI, Hubbard SM, De Vita VT, et al. Factors predicting long-term survival in diffuse mixed histocytic or undifferentiated lymphoma. Blood 1981; 58: 45–51.
  • Jagannath S, Velasquez WS, Tucker SL et al. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol 1986; 4: 859–865.
  • Coiffier B, Gisselbrecht C, Vose JM et al. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 1991; 9: 211–219.
  • Cowan RA, Harris M, Jones M, Crowther D. DNA content in high and intermediate grade non-Hodgkin's lym-phoma—prognostic significance and clinipathological correla-tions. Br J Cancer 1989; 60: 904–1010.
  • Shipp MA. Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has “high risk” disease? Blood 1994; 83: 1165-1173.
  • Fisher RI. Treatment of aggressive non-Hodgkin's lym-phomas: lessons from the past 10 years. Cancer 1994; 74: 2657-2661.
  • Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intesive chemothera-py regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006.
  • Salles G, Shipp MA, Coiffer B. Chemotherapy of non-Hodgkin's aggressive lymphomas. Semin Hematol 1994; 31: 46–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.